I am a
Home I AM A Search Login

Papers of the Week

2020 May 14

Epilepsy Behav


Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity.


Szaflarski JP, Sadek A, Greve B, Williams P, Varner JA, Moseley BD
Epilepsy Behav. 2020 May 14; 109:107127.
PMID: 32417382.


The objective of the present trial was to assess efficacy and safety of intravenous (IV) brivaracetam (BRV) vs. lorazepam (LZP) in patients with epilepsy undergoing evaluation in an epilepsy monitoring unit (EMU) who experienced seizures requiring acute treatment.